1. Coffee and Registration

  2. Session 1 - Overviews
  3. ECHA overview

    Valerio Spinosi Valerio Spinosi
    Scientific and Regulatory Officer, ECHA
  4. Update from the Commission

    • Latest policy developments in relation to the implementation of the scientific criteria for the determination of endocrine disrupting properties
    • Implementation of the interim approach on maximum residue limits
    • Management of product authorisations for in situ cases
    • reporting on the implementation of the BPR

    via video link

    Mario Nagtzaam Mario Nagtzaam
    Policy Officer, European Commission, Belgium
  5. Q&A for video link

  6. Member State Overview from France

    • Feedback on the BPR implementation from an MS perspective: quantitative outcomes and progress
    • Interest and difficulties encountered in the harmonization of the assessment and in the working procedures
    • Focus on a key stage in the BPR implementation: From the approval of the active substance to the product(s) application. What are the main challenges for IND and for eCA ? Recommendations for dossier preparation
    • Overview of the expected challenges for the BPR implementation. How to best prepare ourselves?
    Catherine Gourlay-Francé Catherine Gourlay-Francé
    Deputy Director, Regulated Product Assessment Directorate, ANSES
  7. The first five years with BPR – what next?

    Gosia Oledska Gosia Oledska
    Senior Regulatory Specialist Biocide EMEA, Ecolab
  8. Q&A

  9. Refreshments

  10. Session 2 - Product Authorisation
  11. Experiences with approval of Biocidal Product Families

    Marcel Hulsman Marcel Hulsman
    Partner Product Stewardship, Biocides, ERM, the Netherlands
  12. Feedback from the BPF Working Group discussions – possible changes to and limitations on BPF applications

    Adrian Gray Adrian Gray
    Senior Regulatory Manager, Johnson & Johnson
  13. Dow experience with BPF submissions under BPR

    • Introduction
    • Concept of Biocidal Product Families (BPF)
    • Example of Glutaraldehyde BPF
    • Example of CMIT/MIT BPF
    • Outlook for next 2-3 years (upcoming BPR submissions for blends)
    Mandy Osterloh Mandy Osterloh
    Regulatory Manager, Dow Microbial Control
  14. Q&A

  15. Lunch

  16. Session 2 - Product Authorisation continued
  17. In-situ generation; substances and devices – requirements and equivalence

    • Evolvement of evaluation of in-situ systems, from BPD to BPR
    • Different types of system in scope
    • Use of devices
    • Implications to Technical Equivalence
    • Determining the data requirements
    Sara Kirkham Sara Kirkham
    Director, Arrow Regulatory Ltd
  18. Union Authorization of Biocidal Product Families of disinfectant active substances – experiences from the consultancy perspective

    • Regulatory requirements of biocidal product families
    • Definition of meta SPCs considering C&L and intended uses
    • Definition of concentration ranges of meta SPCs: Impact on classification and risk assessments
    • Approaches for efficacy testing: Identification of reference products and read-across
    • Identification of and dealing with Substances of Concern (SoCs)
    Michael Werner Michael Werner
    Managing Director, Prosacon GmbH, Germany
  19. The future of BPFs: how to balance workload and cost for industry as well as regulators

    • How BPFs can reduce workload for industry and eCAs
    • Case study: the ‘risk envelope’ in practice
    • BPF flexibility restrictions: impact and consequences
    • The future of BPFs
    An Vanden Bosch An Vanden Bosch
    Senior Project Scientist, ARCHE Consulting
  20. Q&A

  21. Refreshments

  22. Session 3 - Enforcement
  23. An Overview of the ECHA FORUM subgroup & treated articles (1st enforcement project)

    Eugen Anwander Eugen Anwander
    Senior Scientific Officer, Institute for Environment and Food Safety, Vorarlberg State Service, Austria & Chair of Echa BPR Enforcement Forum, Finland
  24. Competent Authorities panel session on enforcement

    • verifiability of label claims
    • legal consequences
    • options to ensure conformity with the BPR
    • tips for industry

    Moderator: Eugen Anwander,  Senior Scientific Officer, Institute for Environment and Food Safety, Vorarlberg State Service, Austria & Chair of ECHA BPR Enforcement FORUM


    • Rosemarie Greiwe, Senior Desk Officer for Chemical Safety, Ministry of Labour, Health and Social Affairs of North Rhine-Westphalia, Germany;
    • Heribert Buergy, Head of Section Market Control and Advice, Federal Office of Public Health, Switzerland;
    • Joe Hermes, Chemical Substances and Products Unit, Ministry of Sustainable Development and Infrastructure, Luxemburg
    • Jorun Holme, Senior Adviser, Section for Chemicals and Product Control, Norwegian Environment Agency, Norway
  25. Close of Day one